BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 643582)

  • 41. [Diurnal variations of the viscosity of bronchial secretions in chronic bronchitis].
    Puchelle E; da Costa de Moraes R; Zahm JM
    Biorheology; 1975 Feb; 12(1):67-71. PubMed ID: 1237329
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapy of bronchitis in childhood with Eprazinone (author's transl)].
    Rudkowski Z; Latos T
    Padiatr Padol; 1980; 15(4):351-64. PubMed ID: 7007990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Rheological and biochemical properties of sputum. Role of infection (author's tansl)].
    Puchelle E; Girard F; Beck G; Hayem A; Bailleul V; Laine A
    Pathol Biol (Paris); 1976 Feb; 24(2):93-6. PubMed ID: 818600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of subpopulations of bronchitic patients for suitable therapy by a dynamic rheological test.
    Braga PC; Allegra L; Bossi R; Guffanti EE; Scarpazza G; Bisetti A; Spada E; Fumagalli G
    Int J Clin Pharmacol Res; 1989; 9(3):175-82. PubMed ID: 2744910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Optimal use of expectorants (current trends)].
    Mirrakhimov MM; Brimkulov NN; Rafibekova ZhS
    Ter Arkh; 1981; 53(1):110-7. PubMed ID: 7013137
    [No Abstract]   [Full Text] [Related]  

  • 46. [Rheological properties of human bronchial secretions: demonstration of proline-rich polypeptides and their role (author's transl)].
    Bailleul V; Richet C; Hayem A; Degand P
    Clin Chim Acta; 1977 Jan; 74(2):115-23. PubMed ID: 12892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Action of sobrerol on mucociliary transport.
    Allegra L; Bossi R; Braga PC
    Respiration; 1981; 42(2):105-9. PubMed ID: 7313328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical trial of a new substance with secretolytic action].
    Bontà L
    Minerva Med; 1969 Sep; 60(75):3525-44. PubMed ID: 5344813
    [No Abstract]   [Full Text] [Related]  

  • 49. [Anomalies of mucus and bronchial pathology in adults].
    Polu JM; Delorme N
    Rev Mal Respir; 1989; 6(6):493-9. PubMed ID: 2690213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of bronchial asthma and bronchitis with mucolytic drugs].
    Chalon Z; Gruszecki J; Hadydoń B
    Pol Tyg Lek; 1966 Jul; 21(27):1040-2. PubMed ID: 5925941
    [No Abstract]   [Full Text] [Related]  

  • 51. Rheological assessment of mucolytic agents on sputum of chronic bronchitics.
    Dippy JE; Davis SS
    Thorax; 1969 Nov; 24(6):707-13. PubMed ID: 5350721
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of bronchial secretions of patients with bronchial asthma and chronic bronchitis on the motility of ciliated cells of the ciliated epithelium].
    Shanina NA; Dykhanov II
    Biull Eksp Biol Med; 1990 Sep; 110(9):321-3. PubMed ID: 2268730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacological effects of N-acetyl-L-cysteine on the respiratory tract. (I). Quantitative and qualitative changes in respiratory tract fluid and sputum (author's transl)].
    Kogi K; Saito T; Kasé Y; Hitoshi T
    Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):569-78. PubMed ID: 7286849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term treatment of the bronchitis syndrome with combinations of a secretolytic agent (Bisolvon-Linctus, Bisulvonamide, Bisolvonmycin)].
    Görlach FW
    Hippokrates; 1969 Nov; 40(21):850-3. PubMed ID: 5382635
    [No Abstract]   [Full Text] [Related]  

  • 55. Rheological study of healthy chicken's pooled tracheobronchial secretions and its modification by mucolytics drugs.
    Carrillo L; Sumano H; Medina-Torres L; Tapia G; Gutiérrez L
    Poult Sci; 2016 Nov; 95(11):2667-2672. PubMed ID: 27418656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mucolytic bisolven (further experiences in the treatment of chronic bronchitis and bronchial asthma)].
    Beritić T
    Lijec Vjesn; 1970; 91(11):1200-2. PubMed ID: 5200810
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
    Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
    Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The protein constituents of human bronchial washings. Their relationship to the defenses of the respiratory tract (author's transl)].
    Laine A; Hayem A
    Bull Eur Physiopathol Respir; 1977; 13(1):47-56. PubMed ID: 321053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methods for clinical assessment of expectorants: a critical review.
    Lurie A; Mestiri M; Huchon G; Marsac J; Lockhart A; Strauch G; Bergogne-Berezin E; Bignon J; Carbon C; Chwalow J
    Int J Clin Pharmacol Res; 1992; 12(1):47-52. PubMed ID: 1526698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diffusion of 5-fluorocytosine in bronchial secretions in patients with respiratory insufficiency].
    Brasseur P; Bonmarchand G; Caron F; Lecomte F; Leroy J; Humbert G
    Ann Biol Clin (Paris); 1987; 45(6):685-8. PubMed ID: 3439652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.